“LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOSING”. Mediterranean Journal of Hematology and Infectious Diseases 13, no. 1 (October 29, 2021): e2021065. Accessed April 18, 2026. https://www.mjhid.org/mjhid/article/view/4720.